The SBIR grants awarded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the US Army will fund advancements in the Ibis T5000 Biosensor System for new biodefense applications, including the detection and identification of infectious agents within the military blood supply.
Michael Treble, president of Ibis and vice president of Isis, said: “This $2.8 million and other ongoing government contracts will continue to fund advancements in our technology, which we can incorporate into our commercial products for various government, epidemiology and clinical research applications, and eventually into our products targeting larger commercial markets such as clinical diagnostics.”